User banner image
User avatar
  • admin

Posts

WNDR Alpine’s Shepherd Snowboard Named one of Time Magazine’s Best Inventions of 2024

Utah-Based Ski and Board Maker Pioneers Use of Algae and Biotechnology, Paves a More Renewable Way Forward in the Outdoor Industry and Beyond Salt Lake...

Public Transport Smart Cards Business Analysis Report 2024: Transition from Legacy Magnetic Stripe Cards to EMV Chip-Based Cards Fuels Market Expansion – Global Forecast to 2030

Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) — The “Public Transport Smart Cards – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The...

The 2024 World Cities Day China Observance (Shanghai) Opens, Unveiling Practices, Indicators for Sustainable Urban Development

SHANGHAI, Oct. 31, 2024 (GLOBE NEWSWIRE) — As an event to mark the World Cities Day, the 2024 World Cities Day China Observance (Shanghai) and...

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

PDUFA target action date set for December 20, 2024 THE WOODLANDS, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced...

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced...

Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD

– Patient characteristics are consistent with other DLB studies – PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”)...

Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024

Participants in the Phase 2a study experienced rapid and meaningful decreases in depressive symptoms Suicidal ideation decreased by 80% SPN-820 was well-tolerated with few adverse...

INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update

Company to Host Conference Call Today, October 31, at 4:30pm ET BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the...

Arhaus to Report Third Quarter 2024 Results on November 7, 2024

BOSTON HEIGHTS, Ohio, Oct. 31, 2024 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a rapidly growing lifestyle brand and omni-channel retailer...

Looking Glass Photo Transforms Itself into an Outfitter, Introducing Experiential Retail Concept in New Location

Hallmark of Full-Service Photography Boutique is Personalized Guidance and Experiences, from Coaching Sessions and Workshops to Excursions and More BERKELEY, Calif., Oct. 31, 2024 (GLOBE...